Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohort.
- DOI
- 10.1007/s10067-025-07393-0
- Published
- 2025 Apr
- Container
- Clinical rheumatology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10067-025-07393-0,
title = {Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohort.},
author = {Steimer A and Götschi A and Witte T and Scherer A and Brändli J and Nissen MJ and Möller B and Grosswiler S and Kyburz D and Dan D and Rubbert-Roth A and Adler S and Distler O and Baraliakos X and Ciurea A},
year = {2025},
journal = {Clinical rheumatology},
doi = {10.1007/s10067-025-07393-0},
url = {https://doi.org/10.1007/s10067-025-07393-0}
}RIS
TY - JOUR TI - Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohort. AU - Steimer A AU - Götschi A AU - Witte T AU - Scherer A AU - Brändli J AU - Nissen MJ AU - Möller B AU - Grosswiler S AU - Kyburz D AU - Dan D AU - Rubbert-Roth A AU - Adler S AU - Distler O AU - Baraliakos X AU - Ciurea A PY - 2025 JO - Clinical rheumatology DO - 10.1007/s10067-025-07393-0 UR - https://doi.org/10.1007/s10067-025-07393-0 ER -
APA
A, S., A, G., T, W., A, S., J, B., MJ, N., B, M., S, G., D, K., D, D., A, R., S, A., O, D., X, B., & A, C. (2025). Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohort.. Clinical rheumatology. https://doi.org/10.1007/s10067-025-07393-0
Source records
- pubmed · retrieved 2026-09-26T17:08:52.004Z